Acromegaly

Known as: Acromegaly [Disease/Finding], Somatotropin Hypersecretion Syndromes (Acromegaly), Inappropriate GH Secretion Syndrome (Acromegaly) 
A condition caused by prolonged exposure to excessive HUMAN GROWTH HORMONE in adults. It is characterized by bony enlargement of the FACE; lower jaw… (More)
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2010
Highly Cited
2010
OBJECTIVE The Acromegaly Consensus Group met in April 2009 to revisit the guidelines on criteria for cure as defined in 2000… (More)
  • figure 1
  • table 1
Is this relevant?
Review
2009
Review
2009
OBJECTIVE The Acromegaly Consensus Group reconvened in November 2007 to update guidelines for acromegaly management… (More)
  • figure 1
Is this relevant?
Highly Cited
2008
Highly Cited
2008
CONTEXT Several studies have assessed mortality risk in patients treated for acromegaly. All studies found a mortality that was… (More)
Is this relevant?
Highly Cited
2008
Highly Cited
2008
OBJECTIVE Formal studies of acromegaly have found increased mortality associated with the disorder, although reduction of serum… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • table 1
Is this relevant?
Highly Cited
2005
Highly Cited
2005
BACKGROUND AND AIM The aim of this study was to illustrate the present role of transsphenoidal surgery as primary therapy in GH… (More)
  • table 2
  • table 3
  • table 5
  • table 4
  • table 6
Is this relevant?
Highly Cited
2004
Highly Cited
2004
Studies of acromegaly have shown a doubling of mortality compared with the general population. With the development of new… (More)
Is this relevant?
Review
2000
Review
2000
In February 1999, a workshop was held in Cortina, Italy to develop a consensus defining the criteria for cure of acromegaly. The… (More)
Is this relevant?
Review
1999
Review
1999
Acromegaly is a consequence of chronic growth hormone (GH) excess, due in the majority of cases to a GH-secreting pituitary… (More)
  • table 1
  • figure 1
  • table 2
  • table 3
  • figure 2
Is this relevant?
Highly Cited
1998
Highly Cited
1998
Patients with acromegaly have a reduced life expectancy, with the accepted causes for premature death being vascular and… (More)
Is this relevant?
Highly Cited
1994
Highly Cited
1994
OBJECTIVE The extent to which treatment modifies the excess in morbidity and mortality in acromegaly remains uncertain. This… (More)
Is this relevant?